tetano
Editor, Senior Moderator
Expert Rev Vaccines. 2016 Jan 16. [Epub ahead of print]
[h=1]The Effectiveness of Influenza Vaccination in Different Groups.[/h] Dom?nguez A[SUP]1,[/SUP][SUP]2[/SUP], Godoy P[SUP]2,[/SUP][SUP]3[/SUP], Torner N[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Annual administration of the seasonal influenza vaccine, especially to persons known to be at elevated risk for developing serious complications, is the focus of current efforts to reduce the impact of influenza. The main factors influencing estimated inactivated influenza vaccine efficacy and effectiveness, the results obtained in different population groups, current vaccination strategies and the possible advantages of new vaccines are discussed. The available evidence suggests that influenza vaccines are less effective in the elderly than in young adults, but vaccination is encouraged by public health institutions due to higher mortality and complications. There is no consensus on universal vaccination of children yet economic studies suggest that yearly paediatric vaccination is cost saving. The benefits of herd immunity generated by paediatric vaccination require further study. Newer vaccines should be more and more-broadly protective, stable, easy to manufacture and administer and highly immunogenic across all population groups.
[h=4]KEYWORDS:[/h] Influenza vaccines; effectiveness; efficacy; risk groups; study design; vaccination policies
PMID: 26775669 [PubMed - as supplied by publisher]
[h=1]The Effectiveness of Influenza Vaccination in Different Groups.[/h] Dom?nguez A[SUP]1,[/SUP][SUP]2[/SUP], Godoy P[SUP]2,[/SUP][SUP]3[/SUP], Torner N[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Annual administration of the seasonal influenza vaccine, especially to persons known to be at elevated risk for developing serious complications, is the focus of current efforts to reduce the impact of influenza. The main factors influencing estimated inactivated influenza vaccine efficacy and effectiveness, the results obtained in different population groups, current vaccination strategies and the possible advantages of new vaccines are discussed. The available evidence suggests that influenza vaccines are less effective in the elderly than in young adults, but vaccination is encouraged by public health institutions due to higher mortality and complications. There is no consensus on universal vaccination of children yet economic studies suggest that yearly paediatric vaccination is cost saving. The benefits of herd immunity generated by paediatric vaccination require further study. Newer vaccines should be more and more-broadly protective, stable, easy to manufacture and administer and highly immunogenic across all population groups.
[h=4]KEYWORDS:[/h] Influenza vaccines; effectiveness; efficacy; risk groups; study design; vaccination policies
PMID: 26775669 [PubMed - as supplied by publisher]